Förster resonance energy transfer-based kinase mutation phenotyping reveals an aberrant facilitation of Ca2+/calmodulin-dependent CaMKIIα activity in de novo mutations related to intellectual disability

• Published in: Frontiers in molecular neuroscience Vol. 15; p. 970031
• Main Authors: Fujii, Hajime, Kidokoro, Hiroyuki, Kondo, Yayoi, Kawaguchi, Masahiro, Horigane, Shin-ichiro, Natsume, Jun, Takemoto-Kimura, Sayaka, Bito, Haruhiko
• Format: Journal Article
• Language: English
• Published: Lausanne Frontiers Research Foundation 01.09.2022; Frontiers Media S.A
• Subjects: Calcium signalling; Calcium-binding protein; Calmodulin; CaMKII; de novo mutation; Etiology; Fluorescence resonance energy transfer; FRET; Genomes; Genotype & phenotype; Glutamic acid receptors (ionotropic); imaging; Intellectual disabilities; intellectual disability; Kinases; Memantine; Molecular Neuroscience; Mutation; N-Methyl-D-aspartic acid receptors; neurodevelopmental disorders; Neurological diseases; Neurons; Phenotypes; Phenotyping; Plasmids; Proteins; Synaptic plasticity; United States > US; Japan
• ISSN: 1662-5099; 1662-5099
• DOI: 10.3389/fnmol.2022.970031

CaMKIIα plays a fundamental role in learning and memory and is a key determinant of synaptic plasticity. Its kinase activity is regulated by the binding of Ca 2+ /CaM and by autophosphorylation that operates in an activity-dependent manner. Though many mutations in CAMK2A were linked to a variety of neurological disorders, the multiplicity of its functional substrates renders the systematic molecular phenotyping challenging. In this study, we report a new case of CAMK2A P212L, a recurrent mutation, in a patient with an intellectual disability. To quantify the effect of this mutation, we developed a FRET-based kinase phenotyping strategy and measured aberrance in Ca 2+ /CaM-dependent activation dynamics in vitro and in synaptically connected neurons. CaMKIIα P212L revealed a significantly facilitated Ca 2+ /CaM-dependent activation in vitro . Consistently, this mutant showed faster activation and more delayed inactivation in neurons. More prolonged kinase activation was also accompanied by a leftward shift in the CaMKIIα input frequency tuning curve. In keeping with this, molecular phenotyping of other reported CAMK2A de novo mutations linked to intellectual disability revealed aberrant facilitation of Ca 2+ /CaM-dependent activation of CaMKIIα in most cases. Finally, the pharmacological reversal of CAMK2A P212L phenotype in neurons was demonstrated using an FDA-approved NMDA receptor antagonist memantine, providing a basis for targeted therapeutics in CAMK2A-linked intellectual disability. Taken together, FRET-based kinase mutation phenotyping sheds light on the biological impact of CAMK2A mutations and provides a selective, sensitive, quantitative, and scalable strategy for gaining novel insights into the molecular etiology of intellectual disability.